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Abbreviations and terms 
ATM  Ataxia telangiectasia mutated 
Chk1/2 Cell cycle checkpoint kinase   
DNA-PK DNA protein kinase  
DSB  DNA double strand break 
HRS                Low dose hyper-radiosensitivity 
γ-H2AX Phosphorylated histone 2AX 
H3  Histone 3 
HDR               High dose-rate, in this thesis 40 Gy/h 
HRR               Homologous recombination repair             
IMRT             Intensity modulated radiation therapy 
IRR                 Increased radioresistance 
LDR                Low dose-rate, in this thesis 0.3 Gy/h   
LET  Linear energy transfer 
NHEJ  Non-homologous end joining 
 p53  Protein 53 kilo Dalton 
PARP  Poly(ADP-ribose) polymerase 
pRb  Retinoblatoma protein 
Early G2-phase checkpoint: ATM-dependent G2-checkpoint activated early in  
 response to doses above ~0.4 Gy (dependent on cell line) 
Sinclair checkpoint: Late responding ATM-independent, dose-dependent G2-
 accumulation of cells 
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1. Introduction 
During recent years, it has become evident that while the number of ionizations 
induced by γ-radiation or X-rays shows a linear relationship to dose, the biological 
responses to small doses of radiation are a more complex affair and can not be predicted on 
the basis of knowledge acquired from irradiation with higher doses. Genomic instability, 
adaptive responses, bystander effects and low dose hyper-radiosensitivity/increased 
radioresistance are radiobiologic phenomena observed after low-dose irradiation with the 
traits in common that not all cell and tissue models show the same response, and that there 
is no “true” dose-response - the effect is either on or off (1). However, the mechanisms 
involved are different and understanding the biologic effects of low dose irradiation 
requires separate study of each of these low dose phenomena. In this thesis, the main topic 
is low dose hyper-radiosensitivity (HRS). 
1.1  Low dose hyper-radiosensitivity 
There appear to be two principal types of protection of tissue against low doses of 
X- or -radiation. One is to keep cells alive and functioning by preventing or repairing 
DNA damage. The other is to eliminate potentially mutagenic cells by terminal 
differentiation, immune responses, or inducing cell death. 
Low-dose hyper-radiosensitivity (HRS) is a manifestation of the latter. Cells 
exhibiting HRS are characterized by a high sensitivity to radiation doses below ~0.5  Gy 
(cell line dependent) which is followed by a more radioresistant response per unit dose in 
the dose range  ~ 0.5-1 Gy. This transition towards radioresistance is generally described 
by the term “increased radioresistance” (IRR) (figure 1).  
HRS was first identified in vitro in 1993 (2) after having been observed in mouse 
skin in 1986 (3) and in mouse kidney in 1988 (4). HRS has been observed in cells given 
acute proton and pi-meson irradiation(5-7) as well as in cells given high LET neutrons at a 
low dose-rate (8) and appears to be the default response for all radiation qualities in both 
tumour and normal cell lines (only ~20% of the >50 tested cell lines failed to exhibit HRS 
(9-11)). IRR, on the other hand, is only observed after low LET irradiation and only in 
repair-competent cells lines (12).  
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Figure 1: HRS/IRR in T-47D 
cells. Dashed line represents 
the fit using the Linear 
Quadratic (LQ) model, solid 
line the Induced Repair (IR) 
model 
 
 
 
 
 
 
 
 
 
 
 
Ionizing radiation causes DNA damage as well as mitochondria-dependent 
generation of reactive oxygen species (13). DNA single strand breaks and base damages 
are proficiently repaired by error-free mechanisms while unrepaired (or misrepaired) DNA 
double strand breaks (DSBs) are believed to be the prime cause of radiation induced cell 
death (14). Radiation induced DSBs are chiefly repaired by the efficient process of non-
homologous end joining (NHEJ) though homologous recombination (HRR) contribute to 
repair of  breaks during the S- and G2-phase of cell cycle (15). A core component of 
mammalian NHEJ is DNA protein kinase (DNA-PK) (16). A marked decrease in DNA-PK 
activity was observed in response to a low dose of 0.2 Gy in six cell lines exhibiting HRS, 
whereas DNA-PK activity was increased in the four HRS-negative cell lines which 
indicates a role for NHEJ in the transition from HRS to the IRR survival response (17). 
However, inhibition of DNA-PK did not produce HRS in HRS-negative U373 astrocytoma 
cells in the low-dose range (18) but this was explained by a back-up pathway for NHEJ 
utilizing Ligase III and PARP-1 proposed by Wu et al., who found that the putative 
contribution of HRR to the repair in IR-induced DSBs in G2-phase cells was undetectable 
(19).  While HRR requires extensive homology and normally uses sister chromatid strands 
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as template for repair, NHEJ is used when no template is available. Thus, NHEJ is 
intrinsically error prone because, unless the two ends are compatible, the necessary 
enzymatic modifications of the ends may generate base substitutions, insertions or 
deletions (15). Since NHEJ repair of DSBs thus implies a risk of misrepair, which, if not 
lethal, might lead to potentially cancerous mutations, it may be better for the tissue as a 
whole to sacrifice damaged cells as long as the number is not so large that it impedes the 
function of the tissue/organism.  
1.1.1 The early G2-phase checkpoint 
HRS has been associated with failure to induce the early (active 0-2 h post-
irradiation) and transient (lasting ~12 h) G2-phase checkpoint (20), in which cells 
irradiated in G2-phase are arrested for doses >~0.4 Gy in order to provide time for repair. 
Low dose radiation damaged G2-phase cells are thus allowed to enter mitosis with 
unrepaired injuries resulting in cell death. 
Contrary to the dose-dependent mechanisms by which cells irradiated in G1- or S-
phase accumulate in G2 (Sinclair checkpoint), the “early” G2-checkpoint is ATM-
dependent (20) and independent of dose over the range of 1 to 10 Gy, with a distinct 
activation threshold of ~0.4 Gy (11, 21-23). Activation of the critical damage sensor 
molecule ATM by an autophosphorylation event at serine 1981 is detectable at doses of 0.1 
Gy with a gradual increase until phosphorylation of more than 50% of the ATM molecules 
in the cell after a dose of  0.5 Gy  and saturated expression at larger doses (24). Thus, the 
HRS/IRR transition appears to be coincident with both the induction of the early G2-phase 
checkpoint and activation of ATM.  
One of the earliest detectable downstream targets of ATM is the histone H2A 
variant, H2AX, which is phosphorylated by ATM at Ser-139 (25, 26). Foci of γ-H2AX (a 
phosphorylated histone), detected by immunofluorescence, has been shown to be 
quantitatively the same as DNA DSBs (27) and this assay was used to demonstrate that 
HRS does not reflect a failure of DSB recognition (28). In addition, it was demonstrated 
that HRS-negative cell lines have the same ATM activation pattern as cells with HRS 
whereas they show an early G2-arrest even after low radiation doses that produce 
insufficient damage to induce full ATM activation (11). It was suggested by Krueger et al. 
that the dose-dependent ATM regulatory control is evaded by aberrant early G2-checkpoint 
response in HRS-negative cell lines caused by dissociation between ATM activity and 
early G2-checkpoint function (11).   
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The existence of HRS appears in some cell lines to be associated with an elevated 
level of caspase-3 mediated apoptosis after low-dose exposures (29, 30) suggesting that the 
radiation-damaged G2-phase cells that evade the early G2-checkpoint are disposed of by 
this mechanism when entering mitosis. However, also cell lines deficient in TP53 
induction after irradiation or with mutated TP53 have been shown to display HRS/IRR and 
no increase in apoptosis in response to HRS-inducing doses was observed in BMG-1 cells 
with wild-type TP53 (31). Also Vaganay-juery et al. reported no connection between HRS 
and apoptosis in the six HRS-competent cell lines investigated measured by DNA-PKcs as 
early apoptosis marker (17). This corroborates the hypothesis that the transition from HRS 
to IRR primarily is related to induction of the “early” G2-checkpoint and that the death 
process of the cells entering mitosis with damages is cell line dependent.   
 
1.2 Phenomena with relations to HRS/IRR  
1.2.1 Adaptive response  
The radiation-induced adaptive response was first described by Olivieri et al. in 
1984 (32) as the reduced sensitivity to a challenge irradiation induced by a previous small 
priming dose. Radio-adaptive responses have been observed in vitro and in vivo using 
various end points, such as cell lethality, chromosomal aberrations, mutation induction, 
radiosensitivity, and DNA repair (33). Adaptation is most efficiently induced by doses of 
0.01-0.5 Gy at dose-rates from 0.01-1.0 Gy/min (33) with challenge doses in the range of 
0.5-2 Gy (1). The protective effect has been reported to last for about three generations 
following the priming irradiation (34).  
Both IRR and adaptive response can be inhibited by cycloheximide in V79 hamster 
cells (35), demonstrating the need for protein synthesis in both phenomena. However, 
adaptive response and IRR are not homologous phenomena. Firstly,  activation of 
poly(ADP-ribose) polymerase (PARP) is required for adaptation (34, 36) while inhibition 
of PARP1 induced marked radiosensitization of V79, CHO, and exponentially growing 
T98G cells in the 0.05-0.3 Gy range, but not in confluent T98G cells or U373 cells neither 
of which displays HRS (37). Secondly, the adaptive response has been shown to be 
independent of ATM (38), while ATM is a key factor for activation of the early G2-phase 
checkpoint which is believed to be requisite for IRR (22). Thirdly, the time courses for 
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activation and deactivation is generally much shorter for IRR than for adaptive responses 
(10). 
However, a priming dose of 0.2–0.5 Gy given at a high dose-rate (HDR, i.e., acute 
irradiation) has been shown to temporarily abolish HRS (35, 39-41) but with no significant 
effect on the response to higher doses (40). The time courses for full induction of IRR and 
for full return of HRS appear to be cell line dependent, but take in the order of hours. For 
the T-47D cells used in this study, we found that HRS was abolished 6 h after a HDR 
priming dose of 0.3 Gy, but 24 h after the priming dose, HRS had returned (paper I).  
1.2.2 Dose-rate effects  
For x- or -rays (low LET), dose-rate is one of the principal factors that determine 
the biological consequences. Sublethal damages only become lethal (DSBs) if not repaired 
before a second (in itself also sublethal) injury is inflicted. Prolonged radiation time of a 
given absorbed dose results in a lower density of sublethal damages which in combination 
with repair decreases the probability of coincidence with reduced biological effects as a 
consequence (42). Decrease in cell kill as a result of lowering the dose-rate of a given dose 
is termed the classical dose-rate effect and is very important in radiotherapy because it 
usually is more pronounced in normal tissue as compared to tumour tissue. As the dose-
rate is lowered and the irradiation time protracted, a point is reached at which all sublethal 
damage is repaired. 
Lowering the dose-rate further may invoke an inverse dose-rate effect. There 
appear to be different mechanisms that induce a higher cell kill as the dose-rate is lowered. 
In human cervix cancer HeLa cells (43) and NHIK 3025 cells (44) but not in human breast 
cancer T-47D cells (45) an inverse dose-rate effect was observed, which was demonstrated 
to be due to accumulation of the cells in the radiosensitive G2-phase when the dose-rate 
was lowered from ~0.9 to ~0.3 Gy/h. T-47D cells did also accumulate in G2 during low 
dose irradiation, but the lack of inverse dose-rate effect was ascribed to the observation of 
a  population of arrested G2 cells with pRB protein bound in the nucleus, which might 
protect cells against radiation-induced cell death in G2 (45). 
 On the other hand, the inverse dose-rate effect observed in human prostate 
carcinoma PC3, and human glioma T98G, and A7 cell lines, but not in HRS-negative 
human astrocytoma U373MG cells, was suggested to reflect HRS and be due to the lack of 
induction of repair processes occurring in response to exposures at the lowest dose-rate in 
HRS-competent cell lines (46). In support of this explanation, it was found that the 
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enhanced cell kill in DU-145 cells irradiated at the very low dose-rate (LDR) of 9.4 cGy/h 
equivalent to ~4-5 DSBs/h compared to at the high dose rate (HDR) of 45 Gy/h could be 
attributed to inefficient activation of the damage sensor ATM and its down-stream target 
H2AX; the LDR effects could be abrogated by preactivation of ATM or simulated in 
HDR-irradiated cells by inhibiting ATM function (26). 
The effect on HRS of LDR-priming with dose-rates comparable to the LDR used in 
this thesis has previously been examined in one study. In this a pre-irradiation with total 
doses of 2 or 5 Gy 60Co γ-rays using various LDRs from 5 to 60 cGy/h did not abolish 
HRS in asynchronous T98G cells when the response to an immediate subsequent HDR X-
ray exposure was measured, but HRS was reduced after the higher dose LDR pre-exposure 
compared with the lower dose (47). In paper I, we found that not only did a LDR priming 
exposure (0.3 Gy at 0.3 Gy/h) remove HRS in T-47D cells, but it did not return within the 
14 weeks studied. In paper II, this time course was extended to 14 months and later 
experiments, done more than 2 years after the LDR priming, indicate that this seems to be 
a permanent elimination of HRS.  
1.2.3 Responses mediated by medium transfer (bystander effects) 
Radiation-induced bystander effects are biologic responses in unirradiated cells that 
have received signals from irradiated cells either via cell-to-cell gap junctions or by 
secretion of soluble factors. Experiments involving medium transfer from cells irradiated 
with low LET-radiation to unirradiated cells have demonstrated a highly significant 
reduction in plating efficiency of both normal and malignant recipient cells (48). This 
bystander effect suggested that irradiated cells secreted a molecule into the medium that 
was capable of killing cells when the medium was transferred onto unirradiated cells. The 
precise nature of factors that mediate the bystander effect is unknown, but reactive oxygen 
and nitrogen species as well as various cytokines have been implicated (49). 
While it has been observed that repair-deficient cells produce cytotoxic “bystander” 
effects after - irradiation which reduce the plating efficiency in recipient cells (50-52), 
medium harvested from repair-competent cells -irradiated with a small dose seems to be 
capable of inducing an adaptive response to subsequent irradiation in unirradiated cells 
(53-57). There also appears to be an inverse relationship between the ability to produce 
cytotoxic signals and the presence of HRS/IRR in cell lines (58). 
Consistently, we have not found any cytotoxic effect of medium transfer from 
irradiated T-47D cells. On the contrary, we observed an increase in plating efficiency in 
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cells receiving medium transferred from cells irradiated with 0.3 Gy both at LDR and 
HDR. We also found that medium transferred from T-47D cells irradiated with 0.3 Gy at 
the LDR could remove HRS transiently in recipient unirradiated T-47D cells. However, 
medium transferred from HDR-primed cells did not have this effect (paper II). 
1.2.4 Hypoxia 
In cancer treatment, it is a major problem that tumour cells are to some extent 
protected against radiation damage because they are hypoxic. As a solid tumour expands, 
the ability of the existing vasculature to supply growth factors, nutrients, and oxygen is 
surpassed. Tumour hypoxia can stimulate angiogenesis but the newly formed vasculature is 
malformed and poorly organized resulting in regions with poor delivery of oxygen as well 
as intravenously administered chemotherapeutics (59). Tumour cells that are deprived of 
oxygen are resistant to radiation (and some chemotherapeutic drugs) because oxygen is 
required to prevent the return of short lived radiation induced free radicals to their original 
un-reactive state. As the oxygen concentration increases, the cells become gradually more 
sensitive to radiation and reach a sensitivity about 3 times as high as during anoxia (60).
 
However, prolonged oxygen depletion has been shown, in addition to the radiochemical 
effect, to exert biological effects which can influence the radiation response. Hall et al. 
showed already in 1966 that cells irradiated under chronic extreme hypoxia were more 
radiosensitive than cells irradiated under acutely hypoxic conditions, and consistently, that 
cells reoxygenated following prolonged hypoxia were more radiosensitive than cells not 
pre-treated with hypoxia (61). Although this was shown not to be the case with Chinese 
hamster V79 cells (62), it has been confirmed for another human cervix cancer cell line 
NHIK3025 (63, 64). Koritzinsky et al. found that the intrinsic radiosensitization induced 
by prolonged hypoxia (<4 ppm O2 for 20 h) lasted for 7 hours following reoxygenation and 
could be attributed to biological gene-expression-induced changes, not the altered cell 
cycle kinetics that arise when the cells resume cell cycle progression after the hypoxia 
induced arrest (63). 
Chronic moderate hypoxia does not induce cell cycle arrest. Depending on the cell 
line, cells can adapt to a certain level of hypoxia and grow seemingly indefinitely. T-47D 
cells were cultured in a hypoxia box with 4% O2 in the gas-phase, which between 
reculturings gave a peri cellular oxygen concentration reaching below 0.1% while the 
oxygen concentration did not drop below 3.5% for cell grown in ambient air (65). After 
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being cultured for 7 weeks with 4 % O2 in the box, the radiosensitivity was the same when 
irradiated with acute doses of 137Cs as for cells cultivated in ambient air. 
In paper IV, the effect of moderate chronic hypoxia on HRS was investigated. This 
is particularly of interest in radiotherapy of solid tumours in connection with exploiting 
HRS in ultrafractionation. It was demonstrated that T-47D cells grown for 3-6 weeks in 
4% O2 had lost HRS but they regained it after reoxygenation. In contrast to our previous 
findings (65), the cells that had been cultured at 4% O2 appeared to be slightly more 
resistant to high acute doses than cell cultivated in ambient air. 
1.3 Clinical implications of HRS   
The presence of HRS may have implications for in cancer radiotherapy in which 
the aim is to control the eradication of tumour tissue while minimizing the damage to 
normal tissue. The introduction of intensity modulated radiation therapy (IMRT) in cancer 
treatment results in irradiation of a larger proportion of normal tissue but at lower doses 
when compared to conventional treatment. In some situations, one could fear that HRS will 
tend to increase the effect of low doses in normal tissue and thus negate the benefits of 
using IMRT, in particular in tissues with a pronounced volume effect (66). Since the HRS 
is related to the fraction of cells in G2-phase, it may be of more consequence for early-
responding proliferating tissues, such as skin, than for slowly proliferating normal tissues 
with a small fraction of cells in G2. In support, evidence of HRS has been demonstrated in 
studies with human skin using basal cell density (67) or skin erythema (68, 69) as endpoint 
as well as with mouse skin (70).  
On the other hand, it may be possible to exploit HRS in tumour cell killing. 
However, to compensate for cell proliferation, a decrease in dose-fraction size must be 
accompanied with a decrease in time between fractions which induce a risk of a priming 
effect of the previous fraction reducing the efficacy of the treatment. This may be part of 
the explanation why in vivo experiments have had diverging outcome. For example were 
data from experiments with ultrafractionation of 0.4 Gy per fraction, 3 fractions per day in 
murine DDL1 lymphoma (71) or in human A7 glioblastoma xenografts (72) not showing 
HRS.  
A combined chemo-radio therapy approach has been demonstrated to improve the 
therapeutic potential of ultrafractionation. A protocol using a taxane (paclitaxel), which 
synchronize cells in G2-phase (73), in combination with carboplatin and low dose 
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fractionated radiation was extremely well tolerated by the patients and showed a 
synergistic effect in patients with squamous cell cancer of the head and neck (74). 
Another approach to exploit HRS in tumour tissue is to inhibit the induction of 
IRR. Several biotechnology companies are currently developing improved inhibitors of 
ATM, DNA-PK, Chk1, Chk2, and PARP-1 (12).   
Both for exploitation of HRS in tumour tissue and for protection against HRS in 
normal tissue, knowledge of the transition from HRS to IRR response is requisite. In 
papers I-IV, a number of ways to eliminate HRS from T-47D cells either transiently or 
presumably permanently were demonstrated. The HRS/IRR transition appeared to be 
affected by a factor that LDR primed cells induced in the medium if serum was present 
during LDR priming. These findings prompted further investigations in pursue of a 
mechanistic understanding of the phenomena.  
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2. Experimental models and techniques 
2.1 Cell line 
The T-47D cell line was established from the pleural effusion of a 54 year old 
patient with breast carcinoma in 1974 (75). The cells exhibit epithelial morphology and 
form monolayers in culture. T-47D cells are hemizygous for the p53 gene and contain a 
single point mutation in the remaining allele at codon 194 (76).  
A subculture of T-47D cells was primed august 2005 with 0.3 Gy at 0.3 Gy/h and 
cultured as a stock culture since then, interrupted by two periods of approximately two 
weeks during which the cells were stored in liquid nitrogen. These cells are denoted T-
47D-P. 
2.2 Clonogenic survival assay 
The presence and degree of HRS was measured using the clonogenic survival assay 
technique of Puck and Marcus (77). In short, a certain number of single cells were plated, 
irradiated and subsequently incubated until each single cell had had time to grow into a 
colony. At this time, the flasks were fixated in ethanol and dyed with methylene-blue for 
manual colony counting. The surviving fractions were calculated as the plating efficiency 
of each dose divided by that of the control flasks. 
In order to improve the precision of the colony formation assay, which is necessary 
to detect the rather small deviations in surviving fractions in the HRS/IRR region, different 
methods have been used. The most common is to identify single cells by use of a cell sorter 
(78, 79). However, in the present experiments with T-47D cells, making dilutions after 
counting the cells in a Bürker-chamber provided significant and reproducible data. For all 
doses up to 2 Gy, the cells were seeded from the same dilution as the controls with 200 
cells/ml and particular care was taken to maintain the homogeneity of the dilution by 
repeated pumping with a 2 ml pipette.  
As described in paper II, trypsinization and plating affected the degree of HRS up 
to 8 h after handling the cells. In order to avoid any artefacts from trypsinization, a time of 
16-20 h was chosen between plating and (challenge-) irradiation even though this implied a 
higher multiplicity (mean number of cells per colony-forming unit) at the time of 
irradiation because the cells had had time to progress through cell cycle. The surviving 
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fraction of irradiated cells (when values were recorded below 1) was therefore corrected 
for increased mean multiplicity per colony-forming unit according to a formula published 
by Gillespie et al. (80). In light of recent publications on bystander effects, the relevance of 
Gillespie’s formula based on the target-hit theory could be questioned for low doses, but 
we have chosen to apply it because T-47D cells did not show any cytotoxic bystander 
effects by medium transfer from irradiated cells (paper II) and it has been demonstrated 
that bystander effects dependent on cellular interaction and functioning gap junctions are 
induced only by radiation with high linear energy transfer (LET), but not by low LET 
radiation (49). 
In the experiments in paper I, where the challenge doses were given 6 and 24 h 
after the priming dose, respectively, the cells were plated after the priming dose. When it 
was discovered, as described in paper II, that trypsinization reduced HRS for at least 8 h, 
the experiments with 6 h between priming dose and challenge dose were repeated with the 
cells plated for colony formation the day before the priming dose was given. The same 
elimination of HRS was found by this assay (data not shown) excluding that the results 
found in paper I were an artefact caused by trypsinization. 
 
2.3 Irradiation 
2.3.1 60Co γ-rays 
The 60Co facilities were situated at the Radium Hospital. For the experiments in 
papers I and II , the flasks with cells attached were -irradiated from below with a 
Molbatron 80 ( T. E. M. Instruments, Crawley, UK). The irradiation field was 25 × 25 cm2 
and the source-to-flask distance was adjusted to yield the dose-rate of 40 Gy/h used for 
acute irradiation. For doses implying a radiation time of more than two minutes, the flasks 
were placed in sealed plastic bags and submerged in an open water bath (42×35 cm2, 
height 20 cm). The water bath maintained a temperature of 37˚C by use of a temperature-
controlled heater (Techne Templette TE-8D, Princeton, NJ, USA) that also kept the water 
in circulation. 
The low dose-rate of 0.3 Gy/h was obtained by shielding the source by a 10 cm 
thick block of Roos metal (Sn 25%, Pb 25%, Bi 50%, melting point 96˚C, specific weight 
9.85 g/cm3).   
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The Mobaltron 80 was replaced by a Theratron 780-C (MDS Nordion , Ontario, 
Canada). At this facility, the cell flasks were placed on a hollow perspex plate. The 
Perspex plate was heated to maintain 37˚C in the medium of the flasks by circulating water 
from a water bath (Grant Instruments, Cambridge, England). The irradiation field was 40 × 
40 cm2 and the source-to-flask distance was 84.5 cm giving a dose-rate of ~ 40 Gy/h. The 
survival curve for T-47D cells used in paper III and IV was drawn from data pooled from 
experiments done with both 60Co -sources. 
The low dose-rate of 0.3 Gy/h was obtained by shielding the source by a 11.4 cm 
thick block of Roos metal. The irradiation field was 40 × 40 cm2 and the source-to-flask 
distance was 66 cm. The temperature of 37˚C was maintained as for the Mobaltron 80, by 
submerging the flasks in sealed plastic bags in the waterbath.  
Dose measurements were done by Torbjørn Furre using thermoluminescence 
dosimetry.  
   
2.3.2 220 kV X-rays 
Cells were irradiated from above by a Pantak HF225 X-ray tube through a 0.5 mm 
copper filter. The flasks were placed in a steel chamber with inner diameter of 25.5 cm and 
lid thickness of 1 mm and the steel chamber was placed on a heat plate maintaining 37˚C 
in the medium of the flasks. The heat plate consisted of an aluminum plate with circulating 
water in tubes from a water bath (Ecoline, Lauda, Germany). 
Dose measurements were was done by Eirik Malinin using alanine dosimetry.  
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3. Summary of the publications 
3.1 Paper I 
Title: Recovery of low-dose hyper-radiosensitivity after a small priming dose 
depends on priming dose-rate 
Paper I investigates the effect of a small priming dose on the pronounced low-dose 
hyper-radiosensitivity of T-47D cells. Since IRR sets in as a result of enough DNA damage 
to exceed the threshold for ATM activation of the early G2-phase checkpoint, 0.3 Gy was 
chosen as priming dose from the survival curve of the T-47D cells where the transition 
from HRS to IRR response occurs at approximately this dose. Consistent with this 
assumption, HRS was removed by the priming dose at 6 h and returned within 24 h. 
Giving the same dose at a low dose-rate of 0.3 Gy/h should reduce the damage 
density and provide enough time for the cells to repair damage concurrently and it could 
therefore be expected that priming at the low dose-rate would not influence HRS. 
Surprisingly, instead we found that not only did the LDR priming dose remove HRS, but 
HRS did not return for the 14 weeks examined in this paper. 
Flow cytometry was used to obtain DNA histograms to illustrate the effect of the 
priming dose on cell cycle distribution and no effect was found by the priming dose at 
either dose-rate. However, the trypsinization and plating caused an increase in the number 
of cells in G1-phase and a corresponding decrease in the number of cells in G1- or S-phase. 
Cells selected and sorted out while in G1-phase were then irradiated and it was found that 
these cells did not exhibit HRS and were more sensitive to larger doses than 
asynchronously growing cells. In the experiments with priming doses, the cells were plated 
for colony formation a certain time after the priming dose and the challenge doses were 
given 6 h or 24 h after the trypsinization and plating. A trend was observed in which the 
cells given the challenge dose 6 h after trypsinization were more sensitive to larger doses 
than those irradiated after 24 h. It was speculated that this could be due to the sensitivity of 
the larger fraction of cells in G1-phase observed in the DNA histograms. 
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3.2 Paper II 
Title: The elimination of low-dose hyper-radiosensitivity by transfer of irradiated 
cell conditioned medium depends on dose-rate 
In paper II it was reported that trypsinization reduced HRS in T-47D cells for at 
least 8 h and for this reason a time of 16-20 h after plating was chosen for challenge 
irradiation. At the time this paper was written, we had cultured two different LDR primed 
T-47D cell cultures for 9 and 14 months, respectively, neither of which showed any signs 
of HRS.  
The different impact of the HDR and LDR priming was further investigated in 
experiments where medium was harvested from the irradiated (0.3 Gy) cells and 
transferred to unirradiated T-47D cells. The recipient cells were exposed to the donor 
medium for 24 h before being plated for colony formation in fresh medium and 
subsequently challenge irradiated 16-20 h later. The medium from HDR irradiated cells 
had no impact on HRS in the recipient cells while medium from LDR primed cells not only 
removed HRS but induced a higher surviving fraction in the low dose irradiated cells than 
in the controls. Even when medium was harvested from the cell cultures that had been 
LDR primed 9 or 14 months earlier it still removed HRS in recipient cells. 
When the donor medium was diluted with fresh medium, the effect was reduced but 
even a 1% dilution still had a slight effect and saturation appeared to occur between 5% 
and 20%.  
The recipient cells regained HRS within 2 weeks. Thus, it was only the LDR 
primed cells in which the absence of HRS was persistent. Apparently, LDR priming but 
not HDR priming induces the T-47D cells to produce or release a factor into the medium. 
This factor in turn removes HRS in cells exposed to it possibly by manipulating the early 
G2-arrest either so it is activated by the smaller amount of ATM or by dissociating the 
activation of the G2-arrest from the ATM dependence. 
When the plating efficiency of cells receiving medium transfer from primed cells 
was measured, there was a significant increase in survival both in cells that received 
medium from LDR and HDR primed cells compared to controls that received fresh 
medium. Thus, there was no cytotoxic bystander effect in T-47D cells and the observed 
protective effect of the medium transfer was dose-rate independent. 
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3.3 Paper III 
Title: Mechanisms of the elimination of low dose hyper-radiosensitivity in T-47D 
cells by low dose-rate priming 
T-47D-P cells, a LDR primed HRS-deficient T-47D cell culture, which by this time 
had been cultured for more than two years after priming, were observed to show a trend of 
decreasing mitotic ratio with increasing radiation dose measured using the mitotic marker 
histone H3 phosphorylation indicating induction of the early G2-checkpoint in response to 
doses in the HRS-range for unprimed T-47D cells. In contrast, the mitotic ratio of the 
unprimed HRS-positive T-47D cells was unaltered compared to unirradiated cells at doses 
between 0.1 and 0.3 Gy, i.e. these cells failed to show a low-dose, early-G2 phase check 
point. Thus, the elimination of HRS in T-47D-P cells can be correlated to induction of the 
early G2-checkpoint in response to doses normally in the HRS range. The persistent 
alteration of the T-47D-P cells was also expressed in an increased resistance towards 
cisplatin.  
The effect of the LDR priming was not impeded by the presence of protein 
synthesis inhibitor 4,6-benzylidene-D-glucose (BG) during LDR priming and the following 
6 h. 
The ability of medium harvested from LDR primed cells to remove HRS in 
recipient cells was found to depend on the presence of serum during the LDR priming. 
However, to our surprise, the cells did not need to be present during the LDR priming as 
long as the medium had previously been exposed to cells. Thus, LDR priming of cell 
conditioned medium seemed to induce the factor which removes HRS in cells exposed to it 
while unprimed or HDR primed cell conditioned medium as well as LDR primed fresh 
medium had no effect on HRS in recipient cells. For the LDR primed cell conditioned 
medium to affect HRS of the recipient cells, serum needed to be present during cell 
conditioning. 
A model was developed on the basis of the data in papers I, II, and III in attempt to 
explain the mechanisms induced by the LDR priming in cooperation with a serum 
constituent.  
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3.4 Paper IV 
Title: Low dose hyper-radiosensitivity in T-47D cells is removed by chronic 
moderate hypoxia but returns after reoxygenation 
Paper IV presents data on how chronic moderate hypoxia affects the 
radiosensitivity of T-47D cells, in particular the response to doses in the HRS-range. To 
irradiate the cells while still hypoxic or after 5 min of reoxygenation, a 220 kVp x-ray 
machine was used instead of the 60Co source used otherwise. When control experiments 
were done with T-47D cells grown in ambient air, it turned out that the higher LET of the 
220 kVp x-rays as compared to 60Co -rays resulted in a shallower HRS-“dip”, i.e. an 
earlier transition from HRS to IRR response. 
X-ray irradiation of T-47D cells that had grown for 3-6 weeks in a hypoxia box 
operated with 4% O2 in the gas phase disclosed a significantly altered response to low 
doses. The hypoxic cells were HRS-deficient and the surviving fractions in the low dose 
range appeared to lie above the LQ-curve (not significant). In order to exclude that the 
radioresistance was due to the low amount of oxygen present during irradiation the 
experiment was repeated with a flushing of the cell flasks 5 min before irradiation with 
ambient air with 5% CO2. This resulted in slightly lower surviving fractions in the low 
dose range, but they still were above the LQ-curve.  
When cells that had been cultured in the hypoxia box operated at 4% O2 for 4 
weeks were reoxygenated in ambient air for 48 h, the survival was best described by the 
LQ-curve, but after 2 weeks in ambient air, HRS was reestablished. The time scale for 
HRS to be reestablished was concordant with the findings in paper II for cells receiving 
medium transfer from LDR primed cells but different from the cells receiving the direct 
HDR (HRS back within 24 h) or LDR irradiation (persistent elimination of HRS). When 
medium was harvested from the cells that had been hypoxic for 4 weeks, the recipient cells 
also lost HRS. Thus, it is tempting to speculate in a connection between the effect of LDR 
priming on cell conditioned medium (paper II) and that of chronic moderate hypoxia in 
activating a factor in the medium. 
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4. Discussion 
There appear to be general consensus on the model associating HRS/IRR to the 
early G2-phase checkpoint as proposed by Marples et al. (2003) and it is corroborated by 
the findings in this thesis. In paper I, the effects of a HDR priming dose of 0.3 Gy on HRS 
in T-47D cells was investigated. The dose size of 0.3 Gy was chosen from the survival 
curve of the T-47D cells since the transition from HRS to IRR response seems to occur at 
approximately this dose. Xu et al. (20) found that HeLa cells arrested in the early G2-phase 
checkpoint were released 12 h after irradiation at which time they began to reenter mitosis. 
Consistently, we found no HRS in the HDR-primed cells in response to a challenge 
exposure given 6 h after the priming dose but a full HRS response to a challenge dose 
given 24 h after the priming dose. A full time scale for the effect of the HDR priming was 
examined in a master thesis by Christiansen (81) in which the duration of the effect was 
found to be approximately 12 h. Thus, the observed effects of the 0.3 Gy HDR priming 
dose are consistent with an induction of the early G2-phase checkpoint. 
Prolonging the exposure time by giving the priming dose of 0.3 Gy at 0.3 Gy/h, one 
would expect that the low density of ionizing events would not be able to raise the levels of 
phosphorylated ATM sufficiently to activate the early G2-phase checkpoint and that the 
LDR primed cells would retain their HRS response. This, however, was not the case. 
Instead HRS seemed to be persistently lost (we have so far tested for almost three years) 
after the LDR priming dose. Experiments measuring the mitotic ratio using the mitotic 
marker histone H3 phosphorylation (paper III) of the unprimed and the LDR primed (more 
than two years previously) T-47D cells indicated an early G2-arrest for the LDR-primed 
cells in response to all doses between 0.1 and 1 Gy while the unprimed T-47D cells 
unaffectedly continued to enter mitosis after challenge doses between 0.1 and 0.3 Gy. The 
two responses corresponded to those observed by Krueger et al. (11) for HRS-deficient and 
HRS-proficient cell lines, respectively. This confirmed our notion that the early G2-
checkpoint somehow is activated even by a dose of 0.1 Gy in the LDR primed cells. We 
were not able to establish the exact threshold dose because the shutter mechanism of the 
available 60Co source was too slow to give doses below 0.1 Gy without changing the dose-
rate.  
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In paper II, experiments with medium transferred from cells primed with 0.3 Gy to 
unirradiated cells confirmed our suspicions that the mechanisms induced by the LDR 
priming dose were of a different nature than those induced by the HDR priming. Cells 
receiving medium from HDR irradiated cells retained their HRS response while cells 
receiving medium form LDR primed cells lost HRS transiently. The data indicate that LDR 
primed cells release a factor into the medium which eliminates HRS in recipient cells. The 
recipient cells regained HRS within two weeks in contrast to the cells given the LDR 
priming, which not only remained without HRS but persistently released the putative factor 
into the medium.  
Dilution of the medium from LDR primed cells led to a reduction of the HRS-
eliminating effect in the recipient cells (paper II). A full effect was obtained at 20% 
dilution suggesting a mechanism of saturation concordant with that of growth factors. This 
inspired an experiment in which the cells were deprived of serum in the medium during the 
LDR priming. The medium was then harvested, filtered, supplied with serum, and 
transferred to unirradiated cells. The recipient cells remained HRS-proficient (paper III) 
indicating that a constituent of the serum which the T-47D cells can not produce 
themselves was requisite for the effect of the LDR priming. 
Experiments with irradiation of the medium alone lead to a surprising result (paper 
III). Transfer of irradiated fresh medium did not influence HRS in the recipient cells, but 
medium that had previously been harvested from unirradiated cells and subsequently, after 
filtration, exposed to 0.3 Gy at LDR (but not HDR) was able to eliminate HRS in recipient 
cells. However, if serum was not present during the cell conditioning, the recipient cells 
retained HRS even if serum was added before LDR irradiation of the medium. 
Exposure to chronic moderate hypoxia (4% O2) also eliminated HRS in T-47D cells 
and induced a factor which, by medium transfer, eliminated HRS in recipient cells (paper 
IV). In the cells that had been grown for 4 weeks at 4% O2 in the gas phase, HRS returned 
within 2 weeks of reoxygenation. Thus, chronic hypoxia appeared to induce effects similar 
to those induced in cells receiving medium transferred from LDR primed cells or LDR 
primed CCM. 
The experiments with cisplatin and bleomycin described in paper III were also 
performed with cells that were incubated with 3% O2 in the gas-phase in the 24 h between 
plating for colony formation (200 cells/flask) and during the 24 h exposure to the cytostatic 
(unpublished data, figure 2). Exposure to 3% O2 in the gas-phase induced a significant 
resistance towards bleomycin (figure 2, panel A) both in wild-type T-47D cells and in T-
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47D cells in which a LDR (0.3 Gy/h) priming dose of 0.3 Gy given more than two years 
earlier had eliminated HRS (denoted T-47D-P cells) (P<0.01 for all dose points in both cell 
cultures (null hypothesis was coincidence of data points from three individual experiments 
with either hypoxic cells or cells grown in ambient air)).  
 
Figure 2: The sensitivity towards bleomycin (panel A) and cisplatin (panel B) was 
measured on T-47D cells and T-47D-P cells (i.e. T-47D cells LDR primed two years 
previously) in either 20 or 3 % O2 
 
Exposure to 3% O2 also appeared to protect both the T-47D cells and the T-47D-P 
cells against 1 g/ml cisplatin though the increases in surviving fraction were not 
significant. 
As described in paper III, the LDR priming also protected the cells against exposure 
to 1 g/ml cisplatin and the T-47D-P cells showed a significantly higher clonogenic 
survival than the unprimed T-47D cells (figure 2, panel B) whereas the cells exposed to 
bleomycin showed a slightly (non-significant) lower survival in T-47D-P compared to T-
47D cells (figure 2, panel A). This difference in responses are probably related to the 
observations that cisplatin pretreatment (1M) has been shown to eliminate HRS in CHO 
cells (9) whereas bleomycin pretreatment did not (82). Interestingly, the protective effect in 
response to cisplatin treatment of moderate hypoxia and a previous LDR priming was 
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additive. Calculating the surviving fraction from un-treated T-47D cells by adding the 
effect of each pre-treatment (LDR priming in T-47D-P cells and 3% O2) gave 0.41 ± 0.10 
compared to the measured surviving fraction of T-47D-P cells in 3% O2 of 0.40 ± 0.10.  
In view of the concordance of the time scale for regaining HRS after exposure to 
medium from LDR primed cells or to chronic moderate hypoxia, it is tempting to 
hypothesize that it is the same factor that is present in the medium after the two different 
treatments. The additive protective effect of moderate hypoxia and LDR priming towards 
cisplatin could be taken to indicate otherwise, but the exposure to 3% O2 in the gas phase 
was for only 24 h in flasks containing only 200 cells. Since T-47D cells grown at the high 
density normal for stock cultures in 20% O2 may experience oxygen concentration close to 
3% between reseedings (65) and still retain HRS, the mechanisms that eliminate HRS are 
most likely induced at much lower oxygen concentrations than was obtained by an 
atmospheric concentration of 3% O2 with such low cell density (200 cells/flask). The 
mechanisms related to the observed protection by moderate hypoxia against the cytotoxic 
effects of cisplatin are therefore more likely to be similar to those protecting the cells 
against exposure to bleomycin and different from those involved in HRS elimination. 
 
It has been suggested that mitochondria may play a crucial role in low dose/low 
dose-rate induced adaptive responses. Pandey et al. (83) irradiated density-inhibited normal 
fibroblasts with 137Cs -rays using either 4 Gy at 198 Gy/h or 0.1 Gy at 0.2 cGy/h. Protein 
(matrix precursor protein frataxin) import was decreased in mitochondria isolated from 
high dose/high dose-rate irradiated cells whereas it was enhanced in mitochondria isolated 
from low dose/low dose-rate irradiated cells. Also the membrane potential  was 
decreased in response to the high dose/high dose-rate and increased in response to the low 
dose/low dose-rate. However, it is not evident how mitochondria can be correlated to the 
data concerning LDR priming of cell conditioned medium without cells present or the 
requirement for serum present during LDR priming. 
 
In paper III, a model was presented which is illustrated in figure 3 (redrawn from 
paper III). Experiments with serum-deprived medium demonstrated the involvement of a 
serum constituent, which in the model is called C. Because of the short time of serum 
deprivation required for inhibition of the effect of LDR priming, it is not likely that C 
crosses the cell membrane to exert its effect. An attachment to a receptor on cell membrane 
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can on the other hand be quickly reversed. It is even possible that continuous fresh 
recruitment of C is required.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Illustration of the model presented in paper III: Panel A: LDR priming without 
cells present. A serum constituent (C) attaches to receptor on the plasma membrane (1) 
resulting in release of a substance A which interact intracellularly with B, a substance 
produced in the cell, forming a complex in which B is modified to B* (2). The A-B* 
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complex is then secreted into the medium (3). LDR irradiation of the medium releases B*
 
from the
 
complex (4) and if the medium is transferred to cells, B* will bind to receptors on 
the recipient cells (5) inducing the non-HRS response (6).. The process (4) can take place 
without cells present indicated by the dashed line. 
Panel B: LDR priming on cells. A serum constituent (C) attaches to receptor on the plasma 
membrane (1) resulting in release of a substance A which interact intracellularly with B, a 
substance produced in the cell, forming a complex in which B is modified to B* (2). LDR 
irradiation of the cell releases B*
 
from the
 
complex (3) before secretion. The presence of 
B* intracellularly induce an autoreaction in which all Bs are modified to B* without 
needing to be linked to A (4). The B*s are secreted (5) and bind to receptors on available 
cells (6) inducing the non-HRS response (7). 
 
 
The next factor introduced in the model is an endogenously supplied substance A 
which in an inactive state is attached to the cell membrane from where it is released by C’s 
reaction with the receptor. When released, it can form a complex with a second 
endogenously supplied substance B.  
In the process of forming the complex, it is assumed that B is modified to B*. One 
could imagine the modification to consist of phosphorylation or methylation, but since the 
modification appears to be irreversible, a conformational change is perhaps more plausible. 
In unirradiated cells, the A-B* is inactive and freely secreted into the medium. The action 
of LDR irradiation is assumed to target the A-B* bond dissociating B* from A and in the 
free state B* will attach to cell membrane receptors and open for an increased sensitivity 
for early G2-arrest. When unirradiated cells received medium transfer form LDR primed 
cells, the effect of the transferred medium depended on the dilution with a full effect at 
20% dilution (paper II). The saturation effect is consistent with receptor mediated effects.  
The action of LDR irradiation on the A-B* complex can take place both in the 
medium and in the cell. However, only when it takes place inside the cell, is the 
elimination of HRS permanent. This could be explained if the presence of B* 
intracellularly induce the modification of B to B*, before B forms a complex with A, in a 
continuous chain of auto-reactions. Another possibility could be that B* acts on the A-B* 
complex in the same way as LDR irradiation by a mechanism that requires the presence of 
certain enzymes and therefore does not take place in the medium. However, protein 
synthesis inhibition did not affect the elimination of HRS by LDR irradiation (paper III) 
which makes B a more likely target for the actions of B*. 
When B* is attached to a receptor on the cell membrane, the B*-receptor complex 
is thought to activate a sensor that responds to signals induced by HDR challenge doses as 
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low as and perhaps even lower than 0.1 Gy by induction of the early G2-checkpoint 
through a pathway which either evades or changes the threshold dose for the ATM-control. 
We have initiated microarray analysis of mRNA regulation, which hopefully will elucidate 
the pathways that are specifically activated in the LDR primed cells.  
 
The LDR of 0.3 Gy/h was obtained by shielding with 10 cm Roos metal. However, 
Monte Carlo analysis showed no significant LET difference for the LDR and HDR arrays 
and only small deviations were found in the secondary electron spectra which therefore can 
not account for the different effects induced by the two dose-rates. 
In paper II, a theory proposed by Vilenchik and Knudson (84-86) was discussed in 
which it was suggested that at that particular dose-rate that induces DSBs at a rate in the 
order of the induction of endogenous DSBs, the damage was more easily recognized by the 
cells which resulted in optimal error-free DNA repair; this explanation was used to account 
for the inverse dose-rate effect. However, the results in papers III and IV suggest that the 
action of the LDR irradiation can also take place outside the cell and point away from 
DNA damage as the inducer of the observed effects. 
In a cell with diameter of 15 m, a dose of 0.3 Gy at 0.3 Gy/h deposits 
approximately 3.3 x 106 eV per hour. The energy is not deposited uniformly, but is located 
along the tracks of secondary electrons. In the case of X- or γ-rays, 95% of the energy 
deposition events are so-called “spurs”, which have a diameter of about 4 nm, contains up 
to 100 eV, and involves, on average, three ion pairs (OH. and eaq) (42). Thus, the 0.3 Gy 
results in ~33000 spurs per cell or ~99000 OH. radicals per cell.  
Since background radiation does not eliminate HRS, a certain amount of ionizations 
are required, and since HDR irradiation also does not eliminate HRS permanently, it seems 
that time is a necessary factor. One can only speculate on the actions of LDR irradiation on 
the putative A- B* complex but since time is an important factor, a slow reaction with a 
transition state, which depends on a second ionization or radical interaction for the reaction 
to proceed rather than to be reversed, could be imagined. 
 
In paper IV, it was demonstrated that cells, which were grown for 3-6 weeks in a 
hypoxia box with 4% O2 in the gas phase at a density that resulted in a much lower O2 
concentration at the cell surface, lost HRS. Medium from the hypoxic cells removed HRS 
in recipient cells and HRS returned within 2 weeks after reoxygenation, a time scale 
similar to that of unirradiated cells receiving medium transferred from LDR primed cells. 
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Thus, there were indications that the same factor was induced in the medium of the 
hypoxic cells as after LDR irradiation. A suggestion of a mechanism could be that the 
hypoxic T-47D cells that are adapted to atmospheric 4% O2 continuously release or secrete 
reactive species with the same effect on the putative A-B* complex as LDR irradiation. 
When the cells are reoxygenated, the flow of reactive species stops and at that time, the 
cells correlate to cells that has been transiently exposed to medium from LDR primed cells 
containing the putative B* factor. 
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Figure 4: Plating efficiencies of unirradiated cells that had received either 1: Medium 
harvested from irradiated cells (H: at HDR, L: at LDR) or 2: Fresh medium irradiated 
without cells present (HM: at HDR, LM: at LDR) or 3: Medium harvested from 
unirradiated cells; the medium was either unirradiated (CCM) or irradiated without cells 
present (HCCM: at HDR, LCCM: at LDR). The plating efficiency was calculated as 
surviving fraction relative to that of cells receiving fresh unirradiated medium. Error bars 
indicate standard error. P-values are from a two-tailed student’s t-test. 
 
In paper II, figure 8 shows the plating efficiencies of the control flasks of the data 
in figure 4 showing the effect of medium transfer from either LDR or HDR primed cells on 
the radiosensitivity of the recipient cells. Similar measurements were done of the plating 
efficiencies of the control flasks in figure 5 in paper III which had received transfer of 
medium irradiated without cells present. The plating efficiencies, measured relative to that 
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of cells receiving fresh, unirradiated medium, are shown in the present figure 4, which 
include data from both papers II and III as well as unpublished data. The cells pre-treated 
with conditioned medium that had been irradiated without cells present (HCCM and 
LCCM) show enhanced plating efficiency relative to that of cells receiving fresh 
unirradiated medium. The increase is similar to that induced by medium irradiated while 
on cells (H and L). This effect did not depend on dose-rate. Cell conditioning by itself (on 
unirradiated cells) (CCM) or irradiation of fresh medium (LM and HM) did not have any 
significant impact on the ability of the medium to influence colony formation. 
In cells exposed to the HDR irradiated medium, an increase in plating efficiency 
was observed but there was no effect on the response of the exposed cells to small doses. 
When the medium was irradiated at LDR, both an increase in plating efficiency in cells 
exposed to the irradiated medium was observed as well as an early-G2 phase arrest in 
response to doses normally below the IRR threshold dose. Thus, the effects on plating 
efficiency and HRS/IRR appear to be through independent mechanisms.  
The LDR primed cells as well as the cells receiving medium transfer from LDR 
primed cells, transfer of LDR irradiated cell conditioned medium or exposed to chronic 
moderate hypoxia all responded to the lowest doses with surviving fractions above 1. The 
increased plating efficiencies of the controls shown in figure 4 can not explain this 
phenomenon. On the contrary, if the surviving fractions are adjusted accordingly, the 
distance from the data points to the LQ-curve is increased. The surviving fractions above 1 
imply that the plating efficiencies of the irradiated flasks were higher than in the 
unirradiated but also pre-treated controls. A reason for this could be either that the 
irradiated cells form more than one colony or that the colonies of the control flasks merge 
or loosen. This explanation was examined by time-lapse photography of the LDR primed 
as well as unprimed cells with or without a challenge dose of 0.3 Gy by Fenne in her 
master thesis (87). The collected data did not confirm that the observed surviving fractions 
above 1 could be attributed to colony splitting, migration or merging. On the contrary, 
though these phenomena did appear they seemed to mask the effect instead. A second 
hypothesis, in which the control population is assumed to contain a subpopulation in G0-
phase that can be induced to re-enter cell cycle by a small challenge dose, is currently 
being tested. However, in the development of the model illustrated in figure 3 a more 
likely explanation evolved. If B* leads to increased ability to activate the early G2-
checkpoint even by the smallest challenge doses used, the G2-delay may improve the 
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ability of T-47D cells to repair damage that has accumulated under normal growth and 
thereby restore clonogenic ability of a few cells that would otherwise have lost it.  
 
The time-lapse films by Fenne never showed any signs of apoptosis in T-47D cells 
HDR irradiated (X-rays) with 0.3 Gy. Tan et al. (88) also found that T-47D cells failed to 
demonstrate typical DNA fragmentation associated with apoptosis in response to exposure 
to cytotoxic Epipremnum pinnatum (L.) Engl. Hexane extracts and the expression levels of 
caspase-3 mRNA were not significantly regulated. However, they found strong indications 
of Type II non-apoptotic programmed cell death (autophagy) which also could be 
consistent with our film observations. Thus, it is possible that not only apoptosis could be 
associated with HRS as suggested by Enns et al. and Krueger et al. (29, 30) but that Type 
II non-apoptotic programmed cell death could be an alternative in cell lines with defects in 
the apoptotic induction pathway. This is an area for future investigations. 
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5. Conclusions 
The results of the four papers included in this thesis can be summarized in the 
following main conclusions: 
• Exposure of T-47D cells to LDR 60Co -irradiation (0.3 Gy/h) during 1 hour 
changes the phenotype making the early G2-phase checkpoint accessible for 
activation by doses in the HRS-range of wild type T-47D cells. Inhibition of 
protein synthesis does not impede the actions of LDR priming 
• The LDR induced phenotype secretes a factor inducing transitory 
elimination of HRS in cells exposed to it. The effect depends on the 
presence of serum in the medium during LDR irradiation. Dilution of the 
transferred medium showed a saturation effect 
• The factor is also secreted in the unirradiated progeny of LDR primed cells  
• The factor secreted from the LDR primed cells can also be induced by LDR 
irradiation in medium without cells present. This requires that the medium 
has preciously been in cell contact and that serum was present during cell 
contact 
• None of the observed effects of a LDR priming irradiation was observed 
when the same priming dose was given at HDR 
• Chronic moderate hypoxia eliminated HRS in T-47D cells, but HRS 
returned after reoxygenated within the same time frame as the return of 
HRS in cells exposed to medium from LDR primed cells, and medium from 
the hypoxic cells appear to contain the same factor that removes HRS as 
medium from LDR primed cells. 
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6. Future directions 
As mentioned in the discussion, we have initiated microarray analysis of mRNA 
from LDR primed T-47D cell compared to unirradiated cells as well as HDR irradiated 
cells as well as investigations of the mechanisms causing that the plating efficiencies of 
irradiated cells can exceed those of the controls. 
In this thesis, the experiments were designed to elucidate the mechanisms behind 
the surprising observation of the persistent elimination of the HRS response in T-47D cells. 
In addition to pursuing the questions that have emerged in the discussion of this research, 
starting with identification of the serum constituent (denoted C in the model), which 
should be possible through experiments in which certain fractions of the serum are 
removed, it is evident that the investigations should be extended to include more cell lines.  
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